US-China trade war leaves gap for Indian pharma to grow
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
List view / Grid view
News
US Food and Drug Administration sued over Ruzurgi drug approval
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
Pharmaceutical packaging/labelling market to increase 5.3 percent
A new report predicts that the packaging and labelling industry for pharmaceutical products will increase by 5.3 percent.
India to introduce mandatory barcoding of APIs
A report showing high percentages of counterfeit drugs in India has prompted the country to introduce compulsory barcoding for APIs.
FDA dermatology advisors found to accept payments after drug approvals
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
More countries added to the EU-US mutual recognition agreement
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
Air cargo carrier unveils purpose-built pharmaceutical facility in Chicago
Emirates SkyCargo has commenced handling pharmaceutical cargo at a new purpose-built facility in Chicago.
PQE launches the new Digital Governance Business Line
At PQE Group we foster innovation, efficiency and quality services for sustainable regulated compliance solutions.
PDA explores the transformation of healthcare at 4th Annual European Meeting
The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting.
Rabies vaccines shortage puts Delhi on brink of crisis
Decreased supply of anti-rabies vaccines (ARVs) in Delhi causes outbreak of the disease.
SCIEX Triple Quad™ 5500+ LC-MS/MS system – QTRAP® ready launches at ASMS 2019
Building from the company’s best-selling SCIEX Triple Quad™ for over 10 years, users can now get triple quad sensitivity plus QTRAP® functionality in one system.
European supercomputers to aid in medicine development
New supercomputing centres have been selected to support Europe's researchers, industry and businesses to design medicines.
Three more US states announce lawsuits against Purdue
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
Amyloidosis treatment discontinued from clinical trials
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
First treatment for cluster headaches approved in US
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
